Shearman And Sterling


ESG and Competition Law in Asia

August 25 - 26, 2022

Partner Elvira Aliende Rodriguez will speak at the GCR Live Law Leaders Asia Pacific conference organized by Global Competition Review on August 25–26 in Singapore.


BTV Multimedia Group Acquisition of STW Spleisstechnik West

August 24, 2022

Shearman & Sterling advised BTV Multimedia Group on the structuring of the acquisition of all shares in Austrian STW Spleisstechnik West GmbH. Closing of the transaction took place on August 17, 2022.


Eaton Corporation's $2 Billion Fixed-Rate and Sustainability-Linked Bond Financing

August 23, 2022

Shearman & Sterling represented the underwriters in connection with Eaton Corporation's offering of $1.3 billion aggregate principal amount of its 4.150% Sustainability-Linked Notes due 2033 and $700 million aggregate principal amount of its 4.700% senior notes due 2052, totaling $2 billion aggregate principal amount.


Sanctions Round Up: Second Quarter 2022

August 22, 2022

With the war in Ukraine raging on, the U.S. continued to escalate its sanctions response against Russia.  The U.S. announced extensive trade and investment bans that prohibit U.S. persons from making any “new investment” in the Russian Federation, and imposed additional blocking sanctions on Russia’s largest banks and Russian elites. With the future of a revived JCPOA still in doubt, the U.S. resumed sanctions against Iran’s energy sector, taking aim at sanctions evasion networks tied to its state-owned oil company.


Underwriters in $3 Billion Notes Offering By Amgen

August 18, 2022

Shearman & Sterling represented BofA Securities, Morgan Stanley, Credit Suisse Securities (USA) and Deutsche Bank Securities as joint book-running managers and representatives of the underwriters in connection with Amgen’s registered $3 billion notes offering, consisting of $1,250,000,000 4.050% Senior Notes due 2029, $750,000,000 4.200% Senior Notes due 2033 and $1,000,000,000 4.875% Senior Notes due 2053. Amgen is a global biotechnology company that discovers, develops, manufactures and delivers human therapeutics based on advances in cellular and molecular biology.


Waste Connections Acquires Lone Star

August 17, 2022

Shearman & Sterling  acted as lead legal counsel to J.F. Lehman & Company (JFLCO) in its agreement to sell Lone Star Disposal (Lone Star) to Waste Connections US Holdings (Waste Connections).


Fed Imposes New Roadblock on Banks’ Crypto Activities

August 16, 2022

Today, the Fed announced a new procedural requirement for banks seeking to engage in crypto activities. Going forward, a bank must provide formal notice to its lead supervisory contact at the Fed “prior to engaging in any crypto-asset-related activity.” This notice requirement applies to all bank holding companies, savings and loan holding companies, and state-chartered member banks.


ESG Ruling Sends Out Warning to UK Parent Companies

August 16, 2022

Partner Jonathan Swil (London-Litigation), counsel Mehran Massih (Munich-Environmental), counsel Edward Taylor (Hong Kong-International Arbitration) and senior associate James Matthews (London-Litigation) co-authored an article for Law360 titled “ESG Ruling Sends Out Warning to UK Parent Companies.”


Goldman Sachs in Follow-On Public Offering of Inspire Medical Systems

August 15, 2022

Shearman & Sterling advised Goldman Sachs & Co. LLC in connection with the follow-on public offering by Inspire Medical Systems, Inc. of 1,150,000 shares of common stock at a public offering price of $215.00 per share, resulting in aggregate gross proceeds to Inspire of approximately $247.2 million.


Nkarta’s Up To $150 Million At-The-Market Program

August 12, 2022

Shearman & Sterling represented Cowen and Company as sales agent in connection with the commencement of a U.S. at-the-market equity offering program by Nkarta to offer and sell common stock, having an aggregate offering price of up to $150,000,000.